Background: Confluent inferior pulmonary veins (CIPV) is a rare anatomical variant. There is few evidence in the literature regarding anatomic landmarks consideration to guide radiofrequency application in avoiding complications in the esophagus in CIPV cases. Methods: Of 986 consecutive patients undergoing atrial fibrillation (AF) ablation from July 2020 to June 2022, seven (0.7%) had CIPV with a common trunk connecting to the LA diagnosed by 3-dimensional contrast-enhanced computed tomography. Using intracardiac echocardiography (ICE) performed from the left atrium (LA), we measured the posterior wall thickness (PWT) of the CIPV adjacent to the esophagus and compared the measurement with the LA posterior wall thickness (LAPWT) at the left inferior PV level of 25 controls without CIPV. For ablation in CIPV patients, each superior PV was individually isolated, and box isolation of CIPV without ablating the CIPV posterior wall was added (tri-circle ablation technique). Results: The CIPV PWT was 0.7 ± 0.1 mm, while non-CIPV LAPWT was 2.0 ± 0.4 mm (P < 0.001). In the CIPV group, upper and lower portions of the CIPV were both apart from the esophagus (mean distances, 6.7 ± 3.4 mm and 7.9 ± 2.7 mm, respectively). Individual superior PV isolation and box CIPV isolation resulted in complete isolation of all PVs, with no complications. All CIPV patients except one remained AF recurrence-free for 376 ± 52 days. Conclusions: Although CIPV frequency is low, CIPV PWT is very thin and special care is needed during ablation. A “tri-circle” ablation strategy avoids ablating in the thinnest portion of the posterior wall. Further studies are warranted to assess the safety.
28 April 2025 in Journal of Cardiovascular Electrophysiology
Backgrounds. Fusion of the left and right inferior pulmonary veins (PV) (confluent inferior PV, CIPV) is a rare variation. Using intracardiac echocardiography (ICE) from the left atrium (LA), we measured the posterior wall thickness (PWT) of CIPV adjacent to the esophagus and compared it with LA posterior wall thickness (LAPWT) in non-CIPV cases. Methods. Of the consecutive 986 patients undergoing atrial fibrillation (AF) ablation from July 2020 to June 2022, seven (0.7%) had CIPV with a common trunk connecting to the LA diagnosed by 3-dimentinal contrast-enhanced computed tomography. Twenty-five AF patients without CIPV served as control. ICE was done from LA to measure PWT of CIPV and LAPWT of non-CIPV cases at the level of the left inferior PV. For ablation in CIPV patients, each superior PV was individually isolated, and BOX isolation of CIPV without ablating CIPV posterior wall was added. Results. CIPV PWT was 0.7±0.1 mm, while LAPWT of non-CIPV was 2.0±0.4 mm (P<0.001). In CIPV group, the upper and lower portions of CIPV were both apart from the esophagus (mean distances, 6.7±3.4 mm and 7.9±2.7 mm, respectively). Individual superior PV isolation and BOX CIPV isolation resulted in complete isolation of all PVs. There were no complications. All CIPV patients but one remained free from AF recurrence for 376±52 days. Conclusions. Although CIPV frequency is low (0.7%), CIPV PWT is very thin and a special care is needed in ablation. The present ablation strategy is effective for complete PV isolation with a less risk of the esophageal injury.
Backgrounds: Localization of the esophagus and the left atrium (LA) posterior wall thickness (LAPWT) should be taken into account when delivering radiofrequency energy. Intracardiac echo (ICE) advanced into the LA is useful in visualizing LA and surrounding structure by its high and real-time resolution. Methods: In 73 patients (mean age, 68±12; paroxysmal AF in 45), 3-dimensional (3D) esophagus image was created with CARTO Soundstar® and its location was compared with contrast esophagography saved in Carto UNIVU™. LAPWT adjacent to the esophagus was measured at 4 levels: left superior PV (LSPV), intervenous carina (IC), left inferior PV (LIPV), and LIPV bottom. A target AI value was 260 (25W power) on the esophagus region. Results: All patients had the esophagus posterior to the left PV antrum. Creating 3D esophagus and measurement of LAPWT with ICE was done without any complications. ICE esophagus image was completely overlapped with contrast esophagography. LAPWT (mm) was 2.8 (interquartile range, 2.5-3.2), 2.2 (1.9-2.5), 1.9 (1.8-2.1), and 2.1 (1.9-2.4) for LSPV, IC, LIPV and LIPV bottom, respectively, while LA roof thickness 3.2 (2.9-3.6) (P<0.0001 by ANOVA). No residual conduction gap on the esophagus after the first circumferential PV isolation was found in 64 of 73 (88%) patients. Conclusions: ICE inserted into the LA can reliably locate and display the esophagus and its relationship to the LA. LAPWT was thinnest at LIPV level. AI-guide ablation targeting a relatively low target AI value 260 on the esophagus seemed to be effective.
Background: In very high‐power (51–90 W), short‐duration (4 s) radiofrequency applications (QMODE+) using the QDOT MICRO catheter, the optimal power setting at the left atrial (LA) posterior wall adjacent to the esophagus for treating atrial fibrillation (AF) remains unclear. Objective: We evaluated the efficacy and safety of 60 W versus 90 W QMODE+ radiofrequency applications in the periesophageal region. Methods: Fifty AF patients were randomized into two groups based on the QMODE+ power applied to the periesophageal region: 60 W ( n = 24) and 90 W ( n = 26). We compared the incidence of residual conduction gaps in the periesophageal region and endoscopic esophageal lesions, as well as the 1‐year atrial tachyarrhythmia (AT) recurrence rate between the two groups. Results: Median contact force was significantly higher in the 60 W group than in the 90 W group (12.9 g [ IQR 10.2, 15.8] in the 60 W group and 10.9 g [ IQR 8.4, 14.2] in the 90 W group, p < 0.001). The rates of residual conduction gaps (8.3% and 11.5%, respectively, p = 1.00) and esophageal lesions (4.2% in each group) were similar between the two groups. The 1‐year AT recurrence rate did not significantly differ between the two groups (20.8% vs. 7.7%, respectively, p = 0.24). Conclusion: 60 W and 90 W QMODE+ RF applications for the periesophageal region achieved comparable rates of acute conduction block, endoscopy‐detected esophageal injury, and 12‐month AT recurrence‐free survival, although contact force was significantly higher in the 60 W group. Trial Registration: Japan Registry of Clinical Trials (jRCT); jRCT1072230115 (Registered on February 8, 2024)